Leukemia Green Tea
Green tea reduces risk of blood cell and lymph cancers
Green tea reduces risk of blood cell and lymph cancers
Compared to drinking one cup per day, drinking five or more cups of green tea per day reduced the risk of blood cancers by 42% and lymph cancers by 48 percent.
Scientific Medical Reference Source: Green Tea Consumption and Hematologic Malignancies in Japan - The Ohsaki Study. T. Naganuma, S. Kuriyama, M. Kakizaki, et al. American Journal of Epidemiology.
Natural Cancer Treatment Pearls
I recommend making drinking green tea with purified or bottled water known not to have copper. Copper from pipes and water faucets in your house when mixed with green tea may increase your risk of cancer. Excess copper can increase your risk of many cancers. Click here to learn more about copper and cancer concerns.
Green Tea capsule extracts of EGCG can be equal to drinking 10 cups of green tea. If your green tea supplement doesn't show how much EGCG is in it you should switch brands.
Scientific Medical Reference Source: Green Tea Consumption and Hematologic Malignancies in Japan - The Ohsaki Study. T. Naganuma, S. Kuriyama, M. Kakizaki, et al. American Journal of Epidemiology.
Natural Cancer Treatment Pearls
I recommend making drinking green tea with purified or bottled water known not to have copper. Copper from pipes and water faucets in your house when mixed with green tea may increase your risk of cancer. Excess copper can increase your risk of many cancers. Click here to learn more about copper and cancer concerns.
Green Tea capsule extracts of EGCG can be equal to drinking 10 cups of green tea. If your green tea supplement doesn't show how much EGCG is in it you should switch brands.
Acute Lymphoblastic Leukemia Alternative Treatments Reports
Download your free natural cancer treatment reports.
Learn what medical, university and drug company research teams are discovering about successful and unsuccessful Acute Lymphoblastic Leukemia alternative treatments.
Excess copper may feed your cancer cells.
Why should you and your doctor have an interest in Natural Cancer Treatment Products?
"Sixty-two percent of cancer drugs approved by the U.S. FDA between 1981 and 2002 were of natural origin."^
Why should you and your doctor have an interest in Natural Cancer Treatment Products?
"Sixty-two percent of cancer drugs approved by the U.S. FDA between 1981 and 2002 were of natural origin."^
Excess copper may feed cancer cells.
Why should you and your doctor have an interest in Natural Cancer Treatment Products?
"Sixty-two percent of cancer drugs approved by the U.S. FDA between 1981 and 2002 were of natural origin."^
Why should you and your doctor have an interest in Natural Cancer Treatment Products?
"Sixty-two percent of cancer drugs approved by the U.S. FDA between 1981 and 2002 were of natural origin."^
- Home
- Reports
- Acute Lymphoblastic Leukemia ALL
- B Cell Lymphoma
- Bladder Cancer
- Bone Cancer
- Brain Cancer
- Breast Cancer
- Cancer_Genomics
- Cervical Cancer
- Chronic Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Colon Cancer
- Colorectal Cancer
- Endometrial-Cancer-Alternative-Treatment
- Epidermoid Carcinoma
- Esophageal Carcinoma
- Ewing-s-sarcoma-Alternative-Treatment
- Fibrosarcoma
- Gallbladder-Cancer-Alternative-treatment
- Gastric Cancer
- Gastrointestinal-Cancer-Alternative-Treatment
- Head-and-Neck-Cancer-Alternative-Treatment
- Kidney-Cancer-Alternative-Treatment
- Leukemia-Alternative-Treatments
- Liver-Cancer-Alternative-Treatment
- Lung-Cancer-Alternative-Treatments
- Lymphoma-Alternative-Treatment
- Multiple-Myeloma-Alternative-Treatment
- Non-Hodgkins-Lymphoma-Alternative-Treatment
- Oral-Squamous-Cell-Carcinoma-Alternatvie-Treatment
- Ovarian-Cancer-Alternative-Treatment-Reports
- Alternative-Pancreatic-Cancer-Reports
- Prostate-Cancer-Alternative-Treatment-Reports
- Rectal-Cancer-Alternative-Treatment
- Skin-Cancer-Alternative-Treatment
- Stomach-Cancer-Alternative-Treatment
- Thyroid-Cancer-Alternative-Treatments
- Vitamins
- Chemotherapy
- Radiation
- Pain
- Testimonies
- Cancer Terminology
